Skip to main content
Trending storyHistorical stories

SRTD Biotech raises €31.5M seed round for RNA therapies

2 reports2 report sources8 days agoUpdate

Get up to speed on this story

AI Summary

SRTD Biotech, a Jülich, Germany-based startup founded in 2019, closed an oversubscribed €31.5M seed round led by Mérieux Equity Partners, with NRW.BANK named as co-lead in one report. The company is developing marker-triggered, precision mRNA therapies. The funding will support preclinical work toward an IND application, which would allow SRTD to begin clinical trials in the US.

AI-generated from reports · 7 days agoUpdate

Report timeline

Follow the reports to understand different sides of the story.

Nov 9
  1. EU-StartupsTop Deals
    SRTD Biotech raises €31.5M seed for precision mRNA therapies

    Jülich-based SRTD Biotech closed an oversubscribed €31.5M seed round led by Mérieux Equity Partners.

  2. Tech Funding NewsTop Deals
    SRTD Biotech raises €31.5M seed for marker-triggered RNA therapies

    SRTD Biotech, a German startup founded in 2019, raised an oversubscribed €31.5M seed round co-led by Mérieux Equity Partners and NRW.BANK.

Trend for this story

Comparable range current
11
Comparable range peak
13Nov 10 11:00
Change in the last 24 hours
–

Trends only compare the same entities observed consistently and completely, so the scope may be smaller than the current trending statistics. Move the pointer or click the chart to view hourly trending; use the left and right arrow keys on a keyboard to switch.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing